Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (112)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cristol, J.
Right arrow Articles by Canaud, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cristol, J.
Right arrow Articles by Canaud, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 12, Issue 11 2312-2317, Copyright © 1997 by Oxford University Press


ORIGINAL ARTICLES

Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation

J Cristol, J Bosc, S Badiou, M Leblanc, R Lorrho, B Descomps and B Canaud
Departments of Biochemistry and Nephrology, Lapeyronie Hospital, 34295 Montpellier, France; Corresponding author

Oxidative stress can produce profound alterations to cellular membrane lipids, impairing cell metabolism and viability. This phenomenon, previously observed in haemodialysis patients, had been proposed as a significant factor in regard to haemodialysis-related shortened red blood cells (RBC) survival. In the present study, several parameters associated with oxidative stress were evaluated in a group of haemodialysis patients either receiving erythropoietin therapy (n=12, mean erythropoietin dose 88±24 U/kg/week) or not receiving such therapy (n=20), and in 38 controls. Malonyldialdehyde (MDA, nmol/ml), an end-product of lipid peroxidation, and RBC anti-oxidant systems were measured, including RBC &agr;-tocopherol (RBC vitamin E, mg/l), RBC glutathione (GSH, nmol/mgHb), and RBC superoxide dismutase activity (SOD, U/mgHb). Plasma vitamin E concentrations were also evaluated. Finally, oral vitamin E supplementation (500 mg daily), an exogenous antioxidant, was administered for 6 months to seven patients from the dialysis group receiving erythropoietin while oxidative parameters were repeatedly evaluated and erythropoietin requirements monitored, in order to appreciate the therapeutic relevance of an antioxidant supplementation. An elevation of serum MDA was observed in all haemodialysis patients and a significant decrease in RBC vitamin E, despite normal serum vitamin E levels. Furthermore, the reduction in RBC vitamin E was more important in patients treated with erythropoietin. Vitamin E supplementation resulted in a significant increase in RBC vitamin E (from 0.3±0.1 to 1.2±0.2 mg/l of pellet) and a reduction in erythropoietin dose (from 93±24 to 74±26 U/kg/week) while maintaining stable haemoglobin concentrations. These results suggest that the oxidative stress could be one of the resistance factors to erythropoietin response in haemodialysis and that vitamin E supplementation could have a sparing effect on erythropoietin dosage requirement. Key words: antioxidant; erythropoietin; haemodiafiltration; lipid peroxidation; oxidative stress; vitamin E
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Mihov, J. Vogel, M. Gassmann, and A. Bogdanova
Erythropoietin activates nitric oxide synthase in murine erythrocytes
Am J Physiol Cell Physiol, August 1, 2009; 297(2): C378 - C388.
[Abstract] [Full Text] [PDF]


Home page
Ann Clin BiochemHome page
E. Sahin, A. Y. Gocmen, H. Kocak, M. Tuncer, and S. Gumuslu
The association of advanced glycation end-products with glutathione status
Ann Clin Biochem, July 1, 2008; 45(4): 369 - 374.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Terrier, I. Jaussent, A.-M. Dupuy, M. Morena, C. Delcourt, L. Chalabi, C. Rouanet, B. Canaud, and J.-P. Cristol
Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 345 - 353.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Deicher, F. Ziai, A. Habicht, C. Bieglmayer, M. Schillinger, and W. H. Horl
Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis
Nephrol. Dial. Transplant., September 1, 2004; 19(9): 2319 - 2324.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Santangelo, V. Witko-Sarsat, T. Drueke, and B. Descamps-Latscha
Restoring glutathione as a therapeutic strategy in chronic kidney disease
Nephrol. Dial. Transplant., August 1, 2004; 19(8): 1951 - 1955.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Morena, J.-P. Cristol, J.-Y. Bosc, C. Tetta, G. Forret, C.-L. Leger, C. Delcourt, L. Papoz, B. Descomps, and B. Canaud
Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients
Nephrol. Dial. Transplant., March 1, 2002; 17(3): 422 - 427.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Klemm, C. Voigt, M. Friedrich, R. Funfstuck, H. Sperschneider, E.-G. Jager, and G. Stein
Determination of erythrocyte antioxidant capacity in haemodialysis patients using electron paramagnetic resonance
Nephrol. Dial. Transplant., November 1, 2001; 16(11): 2166 - 2171.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Nguyen-Khoa, Z. A. Massy, J. P. De Bandt, M. Kebede, L. Salama, G. Lambrey, V. Witko-Sarsat, T. B. Drueke, B. Lacour, and M. Thevenin
Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment
Nephrol. Dial. Transplant., February 1, 2001; 16(2): 335 - 340.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Weinstein, A. Chagnac, A. Korzets, M. Boaz, Y. Ori, M. Herman, T. Malachi, and U. Gafter
Haemolysis in haemodialysis patients: evidence for impaired defence mechanisms against oxidative stress
Nephrol. Dial. Transplant., June 1, 2000; 15(6): 883 - 887.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Morena, J.-P. Cristol, T. Dantoine, M.-A. Carbonneau, B. Descomps, and B. Canaud
Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients
Nephrol. Dial. Transplant., March 1, 2000; 15(3): 389 - 395.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. M. ROOB, G. KHOSCHSORUR, A. TIRAN, J. H. HORINA, H. HOLZER, and B. M. WINKLHOFER-ROOB
Vitamin E Attenuates Oxidative Stress Induced by Intravenous Iron in Patients on Hemodialysis
J. Am. Soc. Nephrol., March 1, 2000; 11(3): 539 - 549.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Niwa, C. Naito, A. H. M. Mawjood, and K. Imai
Increased Glutathionyl Hemoglobin in Diabetes Mellitus and Hyperlipidemia Demonstrated by Liquid Chromatography/Electrospray Ionization-Mass Spectrometry
Clin. Chem., January 1, 2000; 46(1): 82 - 88.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Turi, I. Nemeth, I. Varga, and B. Matkovics
Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation
Nephrol. Dial. Transplant., January 1, 1999; 14(1): 252 - 253.
[PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.